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We performed a systematic review of 28 case–control, 17 cohort and seven twin studies of the relationship between family history
and risk of lung cancer and a meta-analysis of risk estimates. Data from both case–control and cohort studies show a significantly
increased lung cancer risk associated with having an affected relative. Risk appears to be greater in relatives of cases diagnosed at a
young age and in those with multiple affected family members. Increased lung cancer risk was observed in association with an affected
spouse and twin studies, while limited, favour shared environmental exposures. The limitations of the currently published
epidemiological studies to infer genetic susceptibility are discussed.
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Lung cancer as the most common cancer in the world represents a
major public health problem (Parkin et al, 2005). Worldwide it
accounts for approximately 1.2 million cancer-related deaths,
while within the United Kingdom, there are approximately 33600
deaths a year, the most common cause of cancer death in both men
and women (Cancer Research UK, 2004a). Tobacco smoking is well
established as the major aetiological risk factor for lung cancer,
contributing to a 10-fold increase in risk in long-term smokers
compared with nonsmokers (Doll and Peto, 1981; IARC, 2004).
Other environmental risk factors include exposure to radiation,
asbestos, heavy metals (arsenic, chromium, nickel), polycyclic
aromatic hydrocarbons and chloromethyl ethers (IARC, 1986).
Lung cancer is frequently cited as an example of a malignancy
solely attributable to environmental exposure. However, it has long
been postulated that individuals may differ in their susceptibility
to environmental risk factors. The only direct evidence for a
genetic predisposition to date is provided by the increased risk of
lung cancer associated with a number of rare Mendelian cancer
syndromes as observed in carriers of constitutional TP53 (Hwang
et al, 2003) and retinoblastoma (Sanders et al, 1989) gene
mutations, as well as in individuals with xeroderma pigmentosum
(Swift and Chase, 1979), Bloom’s (Takemiya et al, 1987) and
Werner’s syndromes (Yamanaka et al, 1997).
Since the 1960s, various case–control and cohort studies of the
relationship between family history and risk of lung cancer have
provided some evidence of familial aggregation of lung cancer
outside the context of the rare Mendelian syndromes. Here, we
have systematically reviewed the published data on familial
aggregation of lung cancer, with particular emphasis on the
factors specific to lung cancer that influence our interpretation of
the epidemiological evidence.
MATERIALS AND METHODS
Identification of studies
A search of the literature for articles that provided estimates of the
familial risks of lung cancer was made using the electronic
database PubMed (www.ncbi.nml.nih.gov/pubmed) for the years
1963 to May 2005. The search strategy included the keywords ‘lung
cancer’, ‘risk’, ‘family history’ and ‘familial aggregation’. Studies
were eligible if lung cancer risk was stratified by family history of
lung cancer. All eligible studies were retrieved and bibliographies
checked for other relevant publications. Review articles and
bibliographies of other relevant studies were hand-searched to
identify additional studies. Unpublished data were not sought.
Articles included for analyses were primary references and
included case–control, cohort and twin studies. Care was taken to
include only primary data or data which superseded earlier work.
Details of the studies were extracted from published articles and
summarised in a consistent manner to aid comparison.
Statistical analysis
A meta-analysis was undertaken to obtain a pooled estimate of
familial lung cancer risks from the published case–control and
cohort studies. No distinction was made between studies that
estimated familial risk from mortality or incidence data, respec-
tively. For the purpose of this analysis, both the odds (OR) ratio
and the ratio of observed to expected number of cases, were
considered to represent relative risks (RR). Where both crude and
adjusted estimates of risk were presented in studies, the adjusted
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risk of lung cancer and family history of the disease was derived as
a weighted average of study-specific estimates of the RR, using
inverse variance weights (Kleinbaum et al, 1982). The logarithm of
the RR (logRR) was assumed to have a normal distribution. If
confidence intervals (CIs) were reported, standard errors (SEs) for
the logRR were calculated. The logRR and the corresponding SEs
were used as data points for the meta-analysis. In studies not
quoting the RR or CIs, these were calculated from the presented
data using two of the following parameters: the RR point estimate,
the p-value, the O-E statistic (difference between numbers
observed and expected) or its variance. Where no statistical
parameters were presented the crude RR and its confidence
intervals were calculated from the raw data.
Studies were analysed jointly using a random-effects model
(DerSimonian and Laird, 1986), which takes into account
heterogeneity among studies in addition to within-study variance.
The percentage variability of the pooled RR attributable to
heterogeneity between studies was quantified using the I
2 statistic
(Higgins and Thompson, 2002).
Meta-regression analysis was used to identify characteristics
contributing to heterogeneity. The characteristics analysed in-
cluded publication year (before or after 1993; the mean year of
publication of studies), type of control group used, verification of
the data collected, type of relative studied, sex of cases, adjustment
for smoking habits in study subjects, adjustment for smoking
habits in relatives and adjustment for family size. A random-effects
weighted linear regression model was used, whereby the study-
specific log RR was regressed on the study characteristic variable
of interest (Thompson, 2001). The weights for the regression
incorporated both the within-study variance as well as the
between-study variance, estimated using maximum likelihood.
Owing to the small number of studies in each meta-regression
analysis, each study characteristic was examined in a univariate
model. Results were expressed as a regression coefficient, which is
the estimated increase or decrease in the logRR per unit increase in
the covariate.
Evidence of publication bias was examined by generating Funnel
plots of RRs (Egger et al, 1997). Studies are plotted in order
of decreasing variance of the logRR. Horizontal lines represent
95% CIs. Each box represents the RR point estimate and its
area is proportional to the weight of the study. The diamond (and
broken line) represents the overall summary estimate, with CIs
given by its width. The unbroken vertical line is at the null value
(RR¼1.0).
All statistical manipulations were undertaken using the program
STATA version 8.0 (Stata Corporation, TX, USA) utilising the
METAN and METAREG modules (Bradburn et al, 1999).
RESULTS
Case–control studies
In all, 31 studies were identified that provided risks of lung cancer
stratified by family history of the disease (Tokuhata and Lilienfeld,
1963a,b; Lynch et al, 1982; Ooi et al, 1986; Samet et al, 1986; Gao
et al, 1987; Kramer et al, 1987; Sellers et al, 1987; Tsugane et al,
1987; Horwitz et al, 1988; Wu et al, 1988, 1996; McDuffie et al,
1989; Wu-Williams et al, 1990; Liu et al, 1991; McDuffie, 1991;
Osann, 1991; Shaw et al, 1991; Pavlakou et al, 1993; Schwartz et al,
1996, 1999; Wang et al, 1996; Brownson et al, 1997; Kreuzer et al,
1998; Mayne et al, 1999; Bromen et al, 2000; Wunsch-Filho et al,
2002; Etzel et al, 2003; Wu et al, 2004; Jin et al, 2005; Matakidou
et al, 2005). Three studies (Lynch et al, 1982; Sellers et al, 1987;
Schwartz et al, 1999) were excluded from the review as the same
data were duplicated in subsequent studies. Table 1 details the
characteristics of the 28 eligible case–control studies. Sample sizes
ranged from 85–2260 (median 563), with a total of 15766 cases
and 18184 controls studied. The types of control subjects used
varied between studies and included randomly selected commu-
nity controls, hospital patients (with or without cancer) and
spouses of cases. Data on the lung cancer status of relatives were
collected in most studies via interview or questionnaire from the
index case or a surrogate responder. Two studies used the medical
records of participants to extract the relevant information, while
five studies sought to verify information of the cancer status of
relatives from death certificates or tumour registries.
Figure 1 shows a plot of the RRs of lung cancer associated with
family history for all 28 case–control studies. The variables
adjusted for in the analysis of each study are detailed in Table 1. In
all, 27 of the studies demonstrated that family history of lung
cancer was associated with an elevated risk in relatives. Of these, 21
were statistically significant. The pooled RR of lung cancer
associated with having an affected relative from all 28 case–
control studies was significantly elevated at 1.82 (95% CI: 1.58–
2.10). There was evidence of significant heterogeneity between the
contributing studies (Pheto0.001; I
2¼59.0%).
Nine studies presented the RR of lung cancer associated with
family history in subjects with an earlier age of onset of the disease.
Three studies (Schwartz et al, 1996; Wu et al, 2004; Matakidou
et al, 2005) selected the age of 60 years as the cutoff between
younger and older subjects, (pooled RR 4.39; 95% CI: 1.33–14.42),
three 55 years (Osann, 1991; Wu et al, 1996; Etzel et al, 2003)
(pooled RR 1.10; 95% CI: 0.73–1.65), two 50 years (Tsugane et al,
1987; Bromen et al, 2000) (pooled RR 1.68; 95% CI: 0.28–10.12)
and one study (Kreuzer et al, 1998) selected 45 years (RR 2.60; 95%
CI: 1.10–6.15).
In total 11 studies provided data specifically on never smokers
(Figure 2). The pooled estimate of the RR across these studies was
1.51 (95% CI: 1.11–2.06). Six studies stratified lung cancer risks
according to the number of affected relatives (Ooi et al, 1986; Shaw
et al, 1991; Wu et al, 1996; Bromen et al, 2000; Jin et al, 2005;
Matakidou et al, 2005). The pooled RR of lung cancer associated
with a single affected relative was 1.57 (95% CI: 1.34–1.84) and for
two or more affected relatives was 2.52 (95% CI: 1.72–3.70).
Figure 3 shows the RRs of lung cancer associated with history of
lung cancer in the spouse of the participant, as estimated by two
case–control studies. Pooling data from these studies, the RR was
2.47 (95% CI: 1.31–4.67).
Cohort studies
Table 2 details the characteristics of the 17 cohort studies that have
investigated the relationship between family history and lung
cancer risk (Cannon-Albright et al, 1994; Goldgar et al, 1994;
Hemminki et al, 1998, 1999; Hemminki and Vaittinen, 1999; Poole
et al, 1999; Hemminki et al, 2001a,b, 2004; Dong and Hemminki,
2001; Czene et al, 2002; Hemminki and Li, 2002, 2003; Li and
Hemminki, 2003, 2004, 2005; Jonsson et al, 2004). In all, 13 of the
studies (Cannon-Albright et al, 1994; Hemminki et al, 1998, 1999,
2001a,b, 2004; Hemminki and Vaittinen, 1999; Dong and
Hemminki, 2001; Czene et al, 2002; Hemminki and Li, 2002,
2003; Li and Hemminki, 2003, 2004) were excluded from the meta-
analysis as their data were replicated in subsequent studies. From
the studies examining the Swedish Family Cancer Database, the
study by Li and Hemminki (2005) was included in the pooled
analysis as it examined the largest data set.
Figure 1 shows the RRs of lung cancer associated with family
history of the disease in the four cohort studies. All four studies
demonstrated a significantly increased familial lung cancer risk.
The pooled RR based on these studies was 2.01 (95% CI: 1.62–
2.50). There was, however, evidence of significant heterogeneity
between the studies (Pheto0.001; I
2¼83.7%).
Young subgroups were presented in three studies, two of which
(Jonsson et al, 2004; Li and Hemminki, 2005) defined these as
those younger than 60 years (pooled OR 2.22; 95% CI: 1.08–4.57).
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Cases Controls Standardising variables
Study Region/country
Years of
data
collection Number Number Type Data sources
a
Type of
relative
Sex of
cases
Recall
bias Age
Smoking
b
(case/
relative)
Family
size Other
Tokuhata (1963b) Maryland, USA 1960–61 270 270 Community IS, NOK, OR, DC 1st degree Both Yes Yes Yes (qual)/yes
(qual)
Yes No
Tokuhata (1963a) New York, USA 1957–60 361 722 Hospital (cancer free) IS, NOK, DC Parent/sibling Both Yes Yes No/no No Race, residence
Ooi (1986) Louisiana, USA 1976–79 336 307 Spouse IS, NOK, OR, DC 1st degree Both Yes Yes Yes (quant)/no No Occupation
Samet (1986) New Mexico, USA 1980–82 518 769 Community IS, NOK Parent Both Yes Yes Yes (quant)/no No Ethnicity
Gao (1987) Shanghai, China 1984–86 672 735 Community IS Parent Female Yes Yes Yes (quant)/no No Education
Kramer (1987) New York, USA N/A
c 427 467 N/A IS, NOK, TR 1st degree Both No Yes No/yes (qual) No Occupation
Tsugane (1987) Tokyo, Japan 1976–85 185 185 Hospital (cancer free) MR 1st/2nd degree Both Yes Yes No/no No Residence
Horwitz (1988) New Haven, USA 1977–82 112 224 Hospital (nonsmoking-
related cancers/cancer
free)
MR Parent/sibling Female Yes Yes No/no No Ethnicity
Wu (1988) Los Angeles, USA 1983–86 336 336 Community IS Parent/sibling Female Yes Yes Yes (quant)/no No Ethnicity
McDuffie (1989) Saskatchewan,
Canada
1979–83 931 1031 Community IS, NOK 1st degree Both Yes Yes No/no No Residence
Wu-Williams
(1990)
Shenyang, China 1985–87 965 959 Community IS 1st degree Female Yes Yes Yes (quant)/no No Education
Liu (1991) Xuanwei, China 1985–86 110 426 Community IS 1st/2nd degree Both Yes Yes Yes (quant)/no No Residence
Osann (1991) California, USA 1969–77 208 208 Screening programme IS 1st degree Female No Yes Yes (quant)/ no No Education, ethnicity
McDuffie (1991) Saskatchewan, USA 1983–86 359 234 Community IS, OR, MR, TR Parent/sibling Both Yes Yes No/no Yes Residence
Shaw (1991) Texas, USA 1976–80 937 955 Community IS, NOK 1st degree Both Yes Yes Yes (quant)/no Yes Ethnicity, residence,
ETS
d
Pavlakou (1993) Athens, Greece 1993 85 140 Community (cancer
free)
IS 1st degree Female Yes Yes No/no No Ethnicity
Schwartz (1996) Detroit, USA 1984–87 257 277 Community IS, NOK, OR 1st degree Both Yes Yes N/a/no No Ethnicity, ETS,
occupation
Wang (1996) Guangdong, China 1990–93 390 390 Hospital (cancer free) IS N/A Both Yes Yes Yes (qual)/no No Residence, education
Wu (1996) USA 1985–90 626 1240 Community IS, NOK, OR 1st degree Female Yes Yes Yes (quant)/yes
(qual)
Yes Residence, ethnicity,
education, ETS
Brownson (1997) Missouri, USA 1986–91 618 1402 Community IS, NOK, OR 1st degree Female Yes Yes No/yes (qual) Yes Ethnicity
Kreuzer (1998) Germany 1990–96 2260 2319 Community IS Parent/sibling Both Yes Yes Yes (quant)/no Yes Residence, asbestos
exposure
Mayne (1999) New York, USA 1982–84 437 437 Community IS, NOK, OR 1st degree Both Yes Yes No/no Yes Residence
Bromen (2000) Bremen, Germany 1988–93 945 983 Community IS 1st degree Both Yes Yes Yes (quant)/yes
(qual)
Yes Residence, ethnicity,
asbestos exposure
Wunsch-Filho
(2002)
Sao Paolo, Brazil 1989–91 285 578 Hospital (non-smoking
related cancers/cancer
free)
IS 1st degree Both Yes Yes Yes (quant)/no No Socioeconomic status
Etzel (2003) Houston, USA 1995–00 806 663 Multidisciplinary clinic IS 1st degree Both Yes Yes Yes (quant)/yes
(qual)
No Ethnicity
Wu (2004) Taiwan 1992–02 108 108 Hospital (cancer free) IS, NOK 1st degree Female Yes Yes No/no No Education, ETS, smoky
coal exposure
Jin (2005) Xuanwei, China 1992–99 740 740 Spouse IS, NOK, OR, DC 1st degree Both Yes Yes Yes (quant)/no Yes Residence, smoky coal
exposure
Matakidou (2005) UK 1999–04 1482 1079 Spouse IS 1st degree Female Yes Yes Yes (quant)/no No Ethnicity
aData sources:I S¼index subject; NOK¼next of kin; OR¼other relative; DC¼death certificates; TR¼tumour registry; MR¼medical records.
bQual¼qualitative; quant¼quantitative.
cN/A¼not available.
dETS¼environmental
tobacco smoke.
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EpidemiologyRelative risk (RR)
RR (95% CI)   % Weight Case–control
Wu et al (2004) 5.70 (1.90−17.10) 0.9 
Horwitz et al (1988) 2.80 (1.02−7.69) 1.0 
Osann et al (1991)  1.90 (0.70−5.16) 1.0 
Wunsch-Filho et al (2002)  1.21 (0.50−2.93) 1.3 
Samet et al (1986)   5.31 (2.21−12.76) 1.3 
Ooi et al (1986)  2.40 (1.00−5.74) 1.3 
Pavlakou et al (1993)   3.91 (1.67−9.15) 1.4 
Tokuhata and Lilienfeld (1963a)  2.35 (1.13−4.89)  1.7 
Wu et al (1988)   3.90 (2.00−7.60) 2.0 
Tokuhata and Lilienfeld (1963b)  3.20 (1.70−6.01) 2.1 
Gao et al (1987)   1.32 (0.72−2.42) 2.3 
Liu et al (1991)  3.75 (2.05−6.86) 2.3 
Schwartz et al (1996)  1.40 (0.80−2.45) 2.5 
Kramer et al (1987)  1.70 (1.00−2.89) 2.7 
McDuffie et al (1991)   1.99 (1.18−3.36) 2.7 
Tsugane et al (1987)  0.75 (0.45−1.25) 2.8 
Mayne et al (1999)  1.83 (1.11−3.02) 2.9 
Wu-Williams et al (1990)  1.80 (1.10−2.95) 2.9 
Bromen et al (2000)   1.67 (1.11−2.51) 3.6 
Wu et al  (1996)   1.29 (0.90−1.85) 4.0 
McDuffie et al (1989)   2.02 (1.41−2.89) 4.0 
Shaw et al (1991)  1.80 (1.30−2.49) 4.4 
Matakidou et al (2005)  1.49 (1.13−1.96) 4.9 
Kreuzer et al (1998)  1.30 (0.99−1.71) 4.9 
Brownson et al (1997)  1.30 (1.00−1.69) 5.0 
Etzel et al (2003)    1.33 (1.03−1.72) 5.1 
Jin et al (2005)   2.05 (1.68−2.50) 5.7 
Subtotal  
Cohort
Goldgar et al (1994)  2.55 (2.08−3.13) 5.7 
Jonsson et al (2004)   2.19 (1.82−2.64) 5.9 
Li Hemminki (2005) 1.70 (1.59−1.82) 6.9 
Subtotal   2.01 (1.68–2.50) 22. 6 
Overall 
1.82 (1.58–2.10)   77. 4 
1.70 (1.20−2.41) 4.1 
Test for heterogeneity: I2=63.9%; P<0.001
Test for heterogeneity: I2=83.7%; P<0.001
Test for heterogeneity: I2=55.5%; P<0.001
1.84 (1.64–2.05) 100. 0
 0.5    2   6
Wang et al (1996) 3.79 (1.00−14.36) 0.6 
Poole et al (1999) 
Figure 1 Forrest plot of Relative risks (RR) of lung cancer in the case–control and cohort studies examining the relationship between family history and
lung cancer risk, CI¼confidence interval.
0.1   0.5     2     6
Study   RR (95% CI)   % Weight
Horwitz et al (1988)    5.70 (0.70  _46.41)  2.0 
Osann et al (1991)    0.70 (0.20  _2.45)  4.8 
Wu et al (2004)    5.70 (1.90  _17.10)  5.9 
Tokuhata and Lilienfeld (1963b)   4.00 (1.39  _11.49)  6.2 
Etzel et al (2003)    0.86 (0.31  _2.39)  6.5 
Shaw et al (1991)    1.10 (0.40  _3.02)  6.6 
Kramer et al (1987)   3.20 (1.20  _8.53)  6.9 
Matakidou (2005)   1.23 (0.65  _2.33)  11.6 
Schwartz et al (1996)    1.40 (0.80  _2.45)  13.2 
Wu et al (1996)    1.29 (0.90  _1.85)  17.7 
Brownson et al  (1997)    1.10 (0.80  _1.51)  18.6 
 Overall  1.51 (1.11–2.06) 100.0
Test for heterogeneity: I2=47.8%; P=0.038 
  Relative risk (RR)
Figure 2 Forrest plot of familial lung cancer risks in never-smokers. RR¼relative risks, CI¼ confidence interval.
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2.53, 95% CI: 0.80–8.00; Goldgar et al, 1994).
Poole et al (1999) reported that probands with only one affected
family member had an RR of 1.9 (95% CI: 1.3–2.7) of developing
lung cancer, while the RR for those with two or more affected
relatives or one affected relative below the age of 50 years was 1.1
(95% CI: 0.4–2.9). Dong and Hemminki (2001) reported an RR for
probands with both a parent and sibling affected by lung cancer of
13.65 (95% CI: 2.57–40.41). RRs of lung cancer associated with
lung cancer in the spouse (Figure 3) were reported by two studies,
the overall RR being statistically increased (1.50; 95% CI: 1.27–
1.76).
Combined case–control and cohort studies
Pooling data from both the case–control and cohort studies
(Figure 1), probands with a family history of lung cancer had an
elevated risk of the disease, which was statistically significant,
overall RR of 1.84 (95% CI: 1.64–2.05). Perhaps not surprisingly,
there was evidence of heterogeneity across the studies (Pheto0.001;
I
2¼63.9%). Pooling data from the five studies estimating familial
lung cancer risks for probands under the age of 60 years, the RR of
lung cancer for this younger subgroup was 2.69 (95% CI: 1.58–
4.58). Probands with a spouse affected by lung cancer (Figure 3)
were also at an elevated risk of lung cancer (1.58, 95% CI: 1.30–
1.92).
A meta-regression analysis was performed to investigate the
contribution of study characteristics to the heterogeneity observed
between the case–control (n¼28) and combined (n¼32) studies.
Analysis was not performed for the cohort studies alone, as there
were too few studies (n¼4). The only variable significantly
contributing to the heterogeneity observed was the year of
publication of the studies analysed. Case–control studies pub-
lished after 1993 reported lower RRs than studies published before
this date ( 0.31, 95% CI:  0.57,  0.04; P¼0.02). Study design
variables such as type of control group, sex of the study subject
and type of relative examined did not significantly account for
heterogeneity. Case–control and cohort studies that verified the
family history data collected through death certificates or tumour
registries reported higher RRs, although this did not reach
statistical significance (0.22, 95% CI:  0.01, 0.45; P¼0.06). Finally,
variables pertaining to the type of RR adjustment applied by each
study (smoking habits, family size) did not appear to affect the
results of the meta-analysis. Studies adjusting for the smoking
habits of the relatives reported lower RRs of lung cancer in
association with family history, although not statistically signifi-
cant ( 0.24, 95% CI:  0.51, 0.04; P¼0.09).
Twin studies
Seven studies were identified (Harvald and Hauge, 1963; Braun
et al, 1994; Braun et al, 1995a,b; Ahlbom et al, 1997; Verkasalo
et al, 1999; Lichtenstein et al, 2000) that have examined the lung
cancer risk in cohorts of twins. Data in all studies have been
collected either from death certificates or cancer registries. Four
studies (Harvald and Hauge, 1963; Braun et al, 1995a; Ahlbom
et al, 1997; Verkasalo et al, 1999) have been superseded by a later
study (Lichtenstein et al, 2000) that combined data from three
different national twin and cancer registries, while the study by
Braun et al (1995b) replicates the data presented by the author’s
previous study (Braun et al, 1994). In total 121424 twins have been
examined for lung cancer concordance in two studies (Braun et al,
1994; Lichtenstein et al, 2000).
One study was based on a registry of almost 16000 male twin
pairs born between 1917 and 1927 who served in the armed forces
in World War II, mortality being followed up from entry into the
armed forces until the end of 1990 (Braun et al, 1994). The
observed (O) frequency of twin pairs, both of which died of lung
cancer, was compared with that expected (E) by chance. The O:E
ratio among monozygotic twins (2.98; 95% CI: 1.55–5.56) did not
exceed that of dizygotic twins (3.99; 95% CI: 2.35–5.79), the overall
rate ratio being 0.75 (95% CI: 0.35–1.6). The study by Lichtenstein
et al (2000) combined data on 44788 pairs of twins listed in the
Swedish, Danish and Finnish twin registries. Lung cancer
concordance was estimated as the proportion of twin pairs with
both twins affected of all ascertained twin pairs with at least one
Relative risk (RR)  
0.5 2 6
RR (95 % CI)  % Weight   Case–control 
Tokuhata and Lilienfeld (1963a)  1.96 (0.12–32.01)  0.5 
Shaw et al (1991)   2.50 (1.30–4.81)  7.9 
Subtotal  2.47 (1.31–4.67) 8.3 
Cohort 
Jonsson et al (2004)  1.75 (1.29–2.37)  26.0 
Hemminki et al (2001a)   1.43 (1.33–1.54)  65.7 
Subtotal  1.49 (1.27–1.76)   91.7  
Overall   1.58 (1.30–1.92)   100.0
Test for heterogeneity: I2=30.3%; P=0.231 
Test for heterogeneity: I2=0.0%; P=0.868 
Test for heterogeneity: I2=37.3%; P=0.207 
Figure 3 Forrest plot of Relative risks (RR) of lung cancer associated with history of lung cancer in a spouse. CI¼confidence interval.
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Standardising variables
Study
Region/
country
Years of data
collection
Number of
cases
Data
sources
a Type of relative Sex of cases Age
Smoking
b
(case/relative) Family size Other
Cannon-Albright
(1994)
Utah, USA 1952–92 2477 CR Parent/sibling Both Yes No/no No Sex, birthplace
Goldgar (1994) Utah, USA 1952–92 2228 CR 1st degree Both No No/no No No
Hemminki (1998) Sweden 1958–94 N/A
c CR Offspring Both Yes No/no No Sex
Hemminki and
Vaittinen (1999)
Sweden 1960–94 35831 CR Offspring Both Yes No/no Yes No
Hemminki (1999) Sweden 1958–94 N/A CR Parent Both Yes No/no N/A No
Poole (1999) USA 1959–72 877 IS Parent/sibling Female Yes Yes (qual)/no Yes Ethnicity, education,
body mass index,
hormonal factors
Hemminki (2001b) Sweden 1958–94 N/A CR Parent/sibling Both No No/no No No
Hemminki (2001a) Sweden 1958–96 N/A CR Parent Both Yes No/no N/A Sex
Dong (2001) Sweden 1958–96 N/A CR Parent/sibling Both Yes No/no No Sex
Hemminki (2002) Sweden 1961–98 4524 CR Parent Both Yes No/no N/A Sex
Chene (2002) Sweden 1958–96 N/A CR Parent/sibling Both No No/no No No
Hemminki (2003) Sweden 1961–98 N/A CR Parent Both Yes No/no N/A Sex
Li (2003) Sweden 1961–98 4524 CR Parent Both Yes No/no N/A Sex, region, period,
socioeconomic status
Hemminki (2004) Sweden 1991–00 5493 CR Parent/sibling Both Yes No/no Yes Sex, region, period,
socioeconomic status
Li (2004) Sweden 1991–00 5290 CR Parent/sibling Both Yes No/no No Sex, region, period,
socioeconomic status
Jonsson (2004) Iceland 1955–02 2756 CR 1st/2nd/3rd degree Both Yes No/no Yes Sex
Li (2005) Sweden 1961–00 55238 CR 1st degree Both Yes No/no No Sex, region, period,
socioeconomic status
aData sources:C R¼cancer registry; IS¼index subject.
bQual¼qualitative.
cN/A¼not available.
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yaffected. For male twin pairs lung cancer concordance was 0.11 in
monozygotic twins compared to 0.10 in dizygotic ones. For female
twin pairs, lung cancer concordance was 0.09 and 0.01, respec-
tively.
DISCUSSION
The findings from our systematic review and meta-analysis of the
published literature on familial aggregation of lung cancer are
consistent with a two-fold increase associated with family history
with evidence of risk being related to early age of diagnosis and
number of relatives affected.
The interpretation of these studies requires caution: while
familial risks are compatible with genetic predisposition, they
could reflect common exposures. Smoking is the most important
environmental risk factor of lung cancer, and the association
between a person’s smoking habits and that of his parents or
siblings has been well documented (Salber and Macmahon, 1961).
Unless adjustment is made for smoking habits, an above-expected
incidence of lung cancer in relatives of lung cancer patients may be
found, in the absence of any genetic effect. To date only four
investigators (Table 1) have attempted to address this issue by
taking into account the smoking habits of both the study subjects
and their family members, reporting RRs comparable with those in
studies making no such adjustment.
To minimise the impact of shared smoking habits in families, a
number of studies have estimated familial risks associated with
nonsmoker status (Figure 2). Pooling of the data in never-smokers
resulted in an elevated risk of lung cancer associated with a family
history of the disease that was statistically significant, supporting
the view that genetic or other environmental factors may play a
role in familial aggregations.
The contribution of shared environmental risk factors to familial
lung cancer risk may also be assessed through risk estimation
associated with an affected spouse since concordance of smoking
habits between spouse pairs has been reported (Macken et al,
2000). Indeed, risk was significantly elevated in probands with an
affected spouse, but remained lower than the risk associated with
an affected relative, consistent with possible genetic factors.
Cohort studies of twins are classically used to separate
genetic and environmental influences on familial aggregation
of a disease. A critical assumption is that MZ and DZ twins display
a comparable degree of similarity because of shared environmental
factors, so that any difference in concordance rates only reflects
genetic factors. The reported concordance ratios of lung cancer
among male twins are almost equal, suggesting a strong
environmental effect shared by twins (i.e. smoking behaviour)
rather than a genetic component, which was widely cited to
counter the propositions that an inherited basis exists for
lung cancer or that the predisposition to smoke was itself genetic.
Twin studies have, however, consistently shown greater
concordance for smoking in MZ than DZ twins (Carmelli et al,
1992), suggesting that environmental exposure is being
confounded by genetic influence. Yet, paradoxically, this con-
cordance difference in smoking behaviour is not reflected in a
concordance difference for lung cancer, although in female twins,
where the prevalence is much lower, it did appear to follow a
more conventional genetic pattern with risks in MZ being greater
than in DZ twins, pointing to genetic predisposition (Lichtenstein
et al, 2000).
One caveat to our meta-analysis is the significant heterogeneity
observed between studies, although its impact on summary risk
estimates is difficult to assess. Given the differences in location,
design and control selection of the various studies, some degree of
heterogeneity may be expected. Some of it is also likely to reflect
differences in statistical methodology between studies, particularly
in the adjustment for smoking habits. The presence or absence of
adjustment for the smoking habits of study participants or their
relatives did not appear to impact significantly on the results of
our meta-analysis, although when adjustment was performed there
was a trend towards reporting lower RR. A further issue inherent
in many case–control studies is that of recall bias. The diagnosis of
lung cancer in an individual may bring to light knowledge or
awareness of lung cancer in relatives. Bias from this source can be
eliminated by collecting the family history data before diagnosis
(prospective/cohort study design). Alternatively, verification of
cancer or cause of death among relatives from medical records or
death certificates will eliminate recall bias. Where possible, we
examined the impact of such verified data and noted that such
studies reported higher rather than lower RRs; support that recall
bias is unlikely to represent a significant confounder.
The only characteristic found to significantly impact on the
heterogeneity observed between studies was the date of study
publication. Studies published before 1993 reported higher RRs of
lung cancer associated with positive family history, indicating time
lag bias and possibly publication bias. However, formal testing
showed no evidence of publication bias between case–control or
cohort studies. Further statistical analysis of studies published
before and after 1993 showed adjustment for family size to be a
significant confounder. Individuals with large families are more
likely to have an affected relative than those with small families;
where average family size differs between cases and controls,
failure to adjust for this might inflate the reported RR, as observed
in the earlier studies. Univariate regression analysis of all the
studies for the presence or absence of adjustment for family size
did not, however, appear to account for the heterogeneity observed
between studies, making it unlikely to significantly impact on the
combined RR.
Type of control, type of relative studied and gender of
participants were examined for their effect on the summary
statistics with no significant associations detected. Although there
were indications that some of these may have contributed to
heterogeneity, each study possessed different combinations of both
desirable and undesirable methodological features, such that no
single factor, other than publication year, consistently increased or
decreased RRs. Sample size limitations prevented detailed multi-
variate analysis, so that other important sources of heterogeneity
may have become apparent if appropriate adjustment for
confounding had been possible.
In summary, this systematic review finds a significant increase
of lung cancer risk associated with having an affected relative, the
risk being further increased with earlier age of onset of the disease
and with multiple affected family members. This suggests that lung
cancer risk may be in part genetically determined. However,
familial studies of lung cancer are problematic as they display high
heterogeneity and it is usually impossible to make a suitable
adjustment for smoking, the major risk factor. Furthermore, the
twin studies and the elevated lung cancer risk associated with an
affected spouse do not favour a genetic susceptibility. Such
limitations formally preclude the drawing of strong inferences
about any genetic influences on lung cancer outside the context of
rare Mendelian disorders. Ultimately, verification of a genetic
predisposition must come from the identification of causal
mutations. Recently, following a genomewide linkage scan, a
candidate locus for lung cancer predisposition has been reported
(Bailey-Wilson et al, 2004). If confirmed, this would provide the
most convincing evidence to date of a genetic susceptibility outside
rare Mendelian disorders.
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